eprintid: 1473162
rev_number: 24
eprint_status: archive
userid: 608
dir: disk0/01/47/31/62
datestamp: 2015-12-10 12:09:39
lastmod: 2021-09-20 00:07:53
status_changed: 2015-12-10 12:09:39
type: article
metadata_visibility: show
creators_name: Marson, CM
creators_name: Matthews, CJ
creators_name: Atkinson, SJ
creators_name: Lamadema, N
creators_name: Thomas, NS
title: Potent and selective inhibitors of histone deacetylase-3 containing chiral oxazoline capping groups and a N-(2-Aminophenyl)-benzamide binding unit
ispublished: pub
divisions: UCL
divisions: B04
divisions: C06
divisions: F56
note: © 2015 American Chemical Society. This is an open access article published under a Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
abstract: A novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contains an oxazoline capping group and a N-(2-aminophenyl)-benzamide unit. Among several new inhibitors of this type exhibiting Class I selectivity and potent inhibition of HDAC3-NCoR2, in vitro assays for the inhibition of HDAC1, HDAC2, and HDAC3-NCoR2 by N-(2-aminophenyl)-benzamide 15k gave respective IC50 values of 80, 110, and 6 nM. Weak inhibition of all other HDAC isoforms (HDAC4, 5, 6, 7, and 9: IC50 > 100 000 nM; HDAC8: IC50 = 25 000 nM; HDAC10: IC50 > 4000 nM; HDAC11: IC50 > 2000 nM) confirmed the Class I selectivity of 15k. 2-Aminoimidazolinyl, 2-thioimidazolinyl, and 2-aminooxazolinyl units were shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)-benzamides previously reported, but the 2-aminooxazolinyl unit was the most potent in inhibiting HDAC3-NCoR2. Many of the new HDAC inhibitors showed higher solubilities and lower binding to human serum albumin than that of Mocetinostat. Increases in histone H3K9 acetylation in the human cell lines U937 and PC-3 was observed for all three oxazolinyl inhibitors evaluated; those HDAC inhibitors also lowered cyclin E expression in U937 cells but not in PC-3 cells, indicating underlying differences in the mechanisms of action of the inhibitors on those two cell lines.
date: 2015-09-10
date_type: published
official_url: http://dx.doi.org/10.1021/acs.jmedchem.5b00545
oa_status: green
full_text_type: pub
primo: open
primo_central: open_green
article_type_text: Journal Article
verified: verified_manual
elements_id: 1056040
doi: 10.1021/acs.jmedchem.5b00545
language_elements: eng
lyricists_name: Marson, Charles
lyricists_id: CMMAR17
actors_name: Poirier, Elizabeth
actors_id: EPPOI23
actors_role: owner
full_text_status: public
publication: Journal of Medicinal Chemistry
volume: 58
number: 17
pagerange: 6803-6818
event_location: United States
issn: 1520-4804
citation:        Marson, CM;    Matthews, CJ;    Atkinson, SJ;    Lamadema, N;    Thomas, NS;      (2015)    Potent and selective inhibitors of histone deacetylase-3 containing chiral oxazoline capping groups and a N-(2-Aminophenyl)-benzamide binding unit.                   Journal of Medicinal Chemistry , 58  (17)   pp. 6803-6818.    10.1021/acs.jmedchem.5b00545 <https://doi.org/10.1021/acs.jmedchem.5b00545>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/1473162/1/acs.jmedchem.5b00545-1.pdf